1. Home
  2. MMI vs CMPX Comparison

MMI vs CMPX Comparison

Compare MMI & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MMI

Marcus & Millichap Inc.

HOLD

Current Price

$25.39

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.27

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMI
CMPX
Founded
1971
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
926.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
MMI
CMPX
Price
$25.39
$5.27
Analyst Decision
Sell
Strong Buy
Analyst Count
2
9
Target Price
$28.00
$14.43
AVG Volume (30 Days)
281.9K
1.7M
Earning Date
01-01-0001
05-28-2026
Dividend Yield
1.95%
N/A
EPS Growth
84.38
N/A
EPS
N/A
N/A
Revenue
$719,700,000.00
N/A
Revenue This Year
$14.04
N/A
Revenue Next Year
$11.35
$830.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.43
$1.33
52 Week High
$36.70
$6.88

Technical Indicators

Market Signals
Indicator
MMI
CMPX
Relative Strength Index (RSI) 39.88 38.14
Support Level $24.89 $4.78
Resistance Level $27.32 $5.86
Average True Range (ATR) 0.79 0.30
MACD -0.09 -0.03
Stochastic Oscillator 8.99 24.22

Price Performance

Historical Comparison
MMI
CMPX

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: